Abstract Body

Background: Large-scale epidemiologic data comparing ischemic stroke between HIV-positive and HIV-negative individuals are limited. We aimed to determine the association of HIV infection and immunodeficiency with ischemic stroke in a large cohort of HIV-positive and HIV-negative individuals with access to care.

Methodology: We conducted a cohort study of HIV-positive and demographically-matched HIV-negative members of Kaiser Permanente (KP) California during 1996-2011. Primary diagnoses of acute ischemic stroke were identified using ICD-9 codes 433.x1, 434 (excluding 434.x0), or 436; patients with a prior stroke within two years were excluded. We used Poisson regression to estimate rate ratios (RR) comparing stroke incidence rates between HIVnegative and HIV-positive subjects, both overall and stratified by recent CD4 cells/μL, recent HIV RNA copies/mL, and nadir CD4 cells/μL. Models were adjusted for age, sex, calendar year, race/ethnicity, socioeconomic status, smoking, alcohol/drug abuse, obesity, diabetes, hypertension, and lipid-lowering therapy. We also assessed risk factors for stroke in the HIV-positive subset.

Results: Among 24,768 HIV-positive and 257,600 HIV-negative subjects, the crude stroke incidence rate per 100,000 person-years was 125 for HIV-positive subjects and 74 for HIV-negative subjects, with an adjusted RR of 1.4 (95% confidence interval [CI]: 1.2-1.7). Compared with HIV-negative subjects, HIV-positive subjects with recent CD4 ≥500/μL or recent HIV RNA <500/mL were not at increased risk of stroke (Table). However, compared with HIV-negative subjects, stroke incidence was increased in HIV-positive subjects with recent CD4 <500/μL and recent HIV RNA ≥500/mL, with a weaker association for nadir CD4 <200/μL (Table). Among HIV-positive subjects, the only HIV-specific risk factor for stroke was recent CD4 <200/μL compared with ≥500/μL (RR 2.5, 95% CI: 1.3-4.6), whereas nadir CD4, recent viral load, and ever having used combination antiretroviral therapy were not independently associated with stroke.

Conclusions: Incidence of ischemic stroke in HIV-positive individuals with recent CD4 ≥500/μL was similar to that of HIV-negative individuals, while those with lower recent CD4 were at increased risk. The weaker results for nadir CD4 compared with recent CD4 suggest an acute effect of immunodeficiency on ischemic stroke incidence.